Still unexplained
The hunt for the origins of Covid-19 has for the past four years been a tangled web of politics, power struggles, and international finger-pointing.
Bharat Biotech on Thursday announced a cut in price of its Covid-19 vaccine ‘Covaxin’ it plans to sell to the states to Rs 400 per dose from the earlier Rs 600.
This follows a widespread criticism of its pricing policy as it sold Covaxin to the Central government at Rs 150 per dose. “Recognising the enormous challenges in the public healthcare system, we have made Covaxin available to state governments at a price of 400/ dose”, Bharat Biotech said in its announcement.
We are deeply concerned with the critical pandemic that India is facing at this time, it added. Serum Institute on Wednesday slashed the price of its Covishield vaccine to Rs 300 per dose from the earlier Rs 400 for states.
Advertisement
Advertisement
